China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 65,511 shares, an increase of 251.4% from the August 31st total of 18,642 shares. Currently, 14.3% of the shares of the company are sold short. Based on an average trading volume of 1,496,161 shares, the short-interest ratio is currently 0.0 days.

China SXT Pharmaceuticals Stock Performance

Shares of NASDAQ SXTC opened at $2.57 on Friday. The company has a quick ratio of 7.76, a current ratio of 7.94 and a debt-to-equity ratio of 0.02. China SXT Pharmaceuticals has a one year low of $1.78 and a one year high of $83,758.80. The business’s fifty day moving average price is $15.21 and its 200-day moving average price is $107.45.

China SXT Pharmaceuticals (NASDAQ:SXTC) last announced its quarterly earnings data on Wednesday, July 1st. The company reported $6.84 earnings per share for the quarter. The firm had revenue of $0.26 million during the quarter.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on SXTC shares. Wall Street Zen raised shares of China SXT Pharmaceuticals to a “sell” rating in a research report on Saturday, August 22nd. Weiss Ratings raised shares of China SXT Pharmaceuticals from a “sell (e)” rating to a “sell (e+)” rating in a report on Wednesday, September 16th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc is a China-based pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicine products. The company’s offerings are designed for use in traditional medicine and health care applications and are marketed primarily in China.

Its product portfolio includes traditional Chinese medicine decoction pieces, finished traditional Chinese medicines and health care products. These products are sold through distribution and retail channels serving pharmacies, medical institutions and other health care-related customers.